pyridoxal phosphate has been researched along with Adenocarcinoma in 11 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate) (DPDP) was tested as a contrast agent for magnetic resonance imaging of pancreatic adenocarcinoma in 15 patients." | 5.07 | Mn-DPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience. ( Bohndorf, K; Gehl, HB; Günther, RW; Hauptmann, S; Klever, P; Lodemann, KP; Matern, S; Schumpelick, V; Urhahn, R, 1993) |
| "Subjects included 498 oesophageal squamous cell carcinomas (OSCCs), 255 gastric cardia adenocarcinomas (GCAs), and an age- and sex-matched sub-cohort of 947 individuals." | 1.43 | Prospective study of serum B vitamins levels and oesophageal and gastric cancers in China. ( Abnet, CC; Dawsey, SM; Fan, J; Murphy, G; Qiao, Y; Ren, J; Selhub, J; Taylor, PR, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nan, H | 1 |
| Giovannucci, EL | 1 |
| Wu, K | 1 |
| Selhub, J | 2 |
| Paul, L | 1 |
| Rosner, B | 1 |
| Fuchs, CS | 1 |
| Cho, E | 1 |
| Ren, J | 1 |
| Murphy, G | 1 |
| Fan, J | 1 |
| Dawsey, SM | 1 |
| Taylor, PR | 1 |
| Qiao, Y | 1 |
| Abnet, CC | 1 |
| Boraschi, P | 1 |
| Donati, F | 1 |
| Gigoni, R | 1 |
| Salemi, S | 1 |
| Faggioni, L | 1 |
| Del Chiaro, M | 1 |
| Boggi, U | 1 |
| Bartolozzi, C | 1 |
| Falaschi, F | 1 |
| Schima, W | 1 |
| Függer, R | 1 |
| Schober, E | 1 |
| Oettl, C | 1 |
| Wamser, P | 1 |
| Grabenwöger, F | 1 |
| Ryan, JM | 1 |
| Novacek, G | 1 |
| Sahani, DV | 2 |
| Kalva, SP | 2 |
| Fischman, AJ | 2 |
| Kadavigere, R | 1 |
| Blake, M | 1 |
| Hahn, PF | 2 |
| Saini, S | 2 |
| Ryan, D | 1 |
| Mueller, P | 1 |
| Eser, G | 1 |
| Karabacakoglu, A | 1 |
| Karakose, S | 1 |
| Eser, C | 1 |
| Kayacetin, E | 1 |
| De Filippo, M | 1 |
| Bocchi, C | 1 |
| Quartieri, L | 1 |
| Corradi, D | 1 |
| Zompatori, M | 1 |
| Gehl, HB | 2 |
| Günther, RW | 2 |
| Klever, P | 2 |
| Hauptmann, S | 2 |
| Urhahn, R | 1 |
| Bohndorf, K | 1 |
| Lodemann, KP | 1 |
| Matern, S | 1 |
| Schumpelick, V | 1 |
| Wang, C | 1 |
2 trials available for pyridoxal phosphate and Adenocarcinoma
| Article | Year |
|---|---|
[Manganese dipyridoxal diphosphate as a new contrast medium in the MRT of benign and malignant pancreatic tumors: initial clinical findings].
Topics: Adenocarcinoma; Adenoma, Islet Cell; Chronic Disease; Contrast Media; Edetic Acid; Humans; Magnetic | 1993 |
Mn-DPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience.
Topics: Adenocarcinoma; Contrast Media; Edetic Acid; Female; Humans; Magnetic Resonance Imaging; Male; Manga | 1993 |
9 other studies available for pyridoxal phosphate and Adenocarcinoma
| Article | Year |
|---|---|
Pre-diagnostic leukocyte genomic DNA methylation and the risk of colorectal cancer in women.
Topics: Adenocarcinoma; Adult; Case-Control Studies; Colorectal Neoplasms; Cysteine; DNA Methylation; DNA, N | 2013 |
Prospective study of serum B vitamins levels and oesophageal and gastric cancers in China.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Cardia; China; Esophageal Neoplasms; Esophage | 2016 |
Secretin-stimulated multi-detector CT versus mangafodipir trisodium-enhanced MR imaging plus MRCP in characterization of non-metastatic solid pancreatic lesions.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Humans; Magnetic Resonance Ima | 2009 |
Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Edetic Acid | 2002 |
Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Colonic Neoplasms; Contrast Media; Edetic Acid; Female; Fluorodeoxygluc | 2005 |
Detection of liver metastases from gastrointestinal cancer: comparision of high resolution MnDPDP enhanced MRI and FDG-PET.
Topics: Adenocarcinoma; Adult; Aged; Contrast Media; Edetic Acid; Female; Fluorodeoxyglucose F18; Gastrointe | 2005 |
Mangafodipir trisodium-enhanced magnetic resonance imaging for evaluation of pancreatic mass and mass-like lesions.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Female; Humans; Liver N | 2006 |
Mangafodipir-DPDP enhanced MRI visualization of a pancreatic adenocarcinoma previously undetected by extracellular contrast enhanced CT and MRI.
Topics: Adenocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Contrast Media; Edetic Acid; Female | 2007 |
Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Topics: Adenocarcinoma; Adenoma, Islet Cell; Adipose Tissue; Adult; Aged; Aged, 80 and over; Blood-Brain Bar | 1998 |